Anjali Morey
Gastroenterology · Kettering, OHNPI 1770722605
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $109,170 of the $139,708 with a category attached, or 78.1%. 29 manufacturers reported payments, led by Madrigal Pharmaceuticals at 41.4% of the total. 2025 is the largest year on record at $84,818, more than ten times the $7,389 reported in 2019. Among gastroenterology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 543 payments — averaging $257.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$58K
- Novo Nordisk$34K
- Phathom Pharmaceuticals, Inc.$25K
- AbbVie$16K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$989
- plus $5K from 23 others
Across 242 payments — averaging $1755.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim International GmbH$290K
- Bausch Health US, LLC$53K
- AbbVie$22K
- Caris MPI, Inc.$22K
- Gilead$18K
- Janssen Research & Development, LLC$12K
- plus $8K from 1 others
What the payments were for
- Consulting fees$9681%
- Speaking & faculty fees$109,17078%
- Travel & lodging$12,5569%
- Food & beverage$16,95012%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 54 | $57,830 |
| Novo Nordisk | 25 | $34,231 |
| Phathom Pharmaceuticals, Inc. | 44 | $24,782 |
| AbbVie | 155 | $15,530 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 88 | $1,580 |
| Takeda Pharmaceuticals U.S.A., Inc. | 51 | $989 |
| Regeneron | 7 | $871 |
| Johnson & Johnson | 32 | $622 |
| QOL Medical, LLC | 23 | $603 |
| Lilly USA, LLC | 8 | $552 |
| E.r. Squibb & Sons, L.L.C. | 4 | $449 |
| Regeneron Healthcare Solutions, Inc. | 11 | $276 |
| Bristol Myers Squibb | 6 | $270 |
| Sanofi | 5 | $268 |
| Janssen Scientific Affairs, LLC | 2 | $192 |
| Intercept Pharmaceuticals, Inc. | 4 | $143 |
| Medtronic | 1 | $120 |
| Nestle Healthcare Nutrition Inc. | 5 | $86 |
| Merck | 4 | $56 |
| Gilead | 1 | $51 |
| Boehringer Ingelheim | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Organon | 2 | $31 |
| Ferring Pharmaceuticals Inc. | 2 | $30 |
| Redhill Biopharma Inc. | 1 | $20 |
| Evoke Pharma, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Mylan Institutional Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$139,708 in reported general payments places this provider in the 95th percentile of 657 gastroenterology providers in Ohio.
Other gastroenterology in Kettering
- Naim AlkhouriWestlake$1.9M
- Pierre GholamCleveland$1.6M
- Anita AfzaliCincinnati$798K
- Mohamed NaemWestlake$708K
- Kara de FeliceCincinnati$427K
- Tasos ManokasColumbus$411K
- Florian RiederCleveland$396K
- Allan PeckCincinnati$391K
- Dany RaadHighland Hills$387K
- Stanley CohenCleveland$338K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.